$USB

Kedia Gunjan sold $1.7M of USB

Kedia Gunjan (President & CEO) sold 27,267 shares of US BANCORP \DE\ (USB) at $62.37 ($1.70M total) on 2026-08-28.

Original reporting
SEC EDGAR · Kedia Gunjan
Published Aug 31, 2026, 8:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 31, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$USB
Neutral
medium confidence
Mentioned
$USB
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$USBNeutralLow
01

Why it matters

The sale represents a modest reduction in insider holdings; likely limited market reaction.

02

Market read

Small insider sale; may cause slight bearish sentiment but unlikely to move the stock materially.

03

What to watch

Potential upcoming strategic moves not reflected in the filing.

Relevance 6/10Novelty 5/10Timing: filed 2026-08-31

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$USBNeutralMedium confidence
Context

President & CEO Kedia Gunjan sold 27,267 shares for $1.7M in a Form 4 filing.

Expected impact

Limited short-term impact; potential slight downward pressure.

Evidence & confidence

Sale amount is relatively small for a large cap; market may view as routine.

Market effects

Minimal effect on banking sector; no broader trend indicated.

U.S. market only; no regional ripple.

Low

Counterpoint

Insider sale could be a routine diversification rather than a negative signal.

Key entities

  • US Bancorp

    U.S. bank holding company (ticker USB).

  • Kedia Gunjan

    President & CEO of US Bancorp.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$USBMed

US Bancorp (USB) Gets a Buy from Oppenheimer

Oppenheimer maintained a Buy rating on US Bancorp (USB) with a $72.00 price target. Truist Financial also issued a Buy, while J.P. Morgan kept a Hold. USB reported Q2 revenue of $10.92B and net profit of $2.18B, up from last year. Insider sentiment is negative, with recent sales by executives.

$USBMed

USB Maintains Rating by Evercore ISI Group -- Price Target Lower

Evercore ISI Group maintained an 'Outperform' rating on U.S. Bancorp (USB) but lowered its price target from $72.00 to $65.00, citing market conditions. USB's GF Value™ is $51.30, suggesting a 9.3% overvaluation. The company's GF Score™ is 84, indicating strong performance but with lower financial strength. Insider activity shows significant selling.

$USBMed

US Fed plans to raise bank oversight thresholds, sources say

The US Federal Reserve plans to raise asset thresholds for stricter oversight of big banks, according to sources. Current thresholds are $100B, $250B, and $700B. The Fed may reindex these, potentially benefiting banks like U.S. Bancorp, Capital One, and PNC Financial. Changes could spur consolidation among mid-size lenders and increase competition, but critics argue it may reduce consumer benefits and increase systemic risks.

$JPMHigh

Banks Lift Prime Rate to 7% as Fed Launches First Tightening Move Since 2023

Major U.S. banks, including JPMorgan, Bank of America, and Citigroup, raised their prime lending rates to 7% following the Federal Reserve's quarter-point increase in the federal funds rate to 3.75%-4%. The Fed cited persistent inflation. Bank stocks fell, reflecting mixed investor sentiment. The Fed projects further rate hikes, with implications for borrowers and the broader economy.